Journal issue - WANFANG MED ONLINE

You Position: Home > Journal issue

Chinese Journal of Oncology

Issue 5, 2022

Items 1-5 of 14

«Preious | of 3 | Next»

Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors

Chinese Journal of Oncology, Volume 44, Issue 5,2022, Pages 416-424, doi:10.3760/cma.j.cn112152-20210709-00504

Retropharyngeal lymph node dissection in head and neck cancers treated with transoral robotic surgery

Chinese Journal of Oncology, Volume 44, Issue 5,2022, Pages 446-449, doi:10.3760/cma.j.cn112152-20200907-00803

CXCL5 inhibits tumor immune of lung cancer via modulating PD1/PD-L1 signaling

Chinese Journal of Oncology, Volume 44, Issue 5,2022, Pages 382-388, doi:10.3760/cma.j.cn112152-20200223-00118

The IL-6/STAT3 signaling pathway mediated by radiotherapy regulates the expression of PD-L1 in esophageal cancer cells

Chinese Journal of Oncology, Volume 44, Issue 5,2022, Pages 389-394, doi:10.3760/cma.j.cn112152-20200320-00236

Safety and feasibility of overlapped delta-shaped anastomosis technique for digestive tract reconstruction during complete laparoscopic right hemicolectomy

Chinese Journal of Oncology, Volume 44, Issue 5,2022, Pages 436-441, doi:10.3760/cma.j.cn112152-20200714-00655

Items 1-5 of 14

«Preious | of 3 | Next»

2024:

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

2003:

2002:

2001:

2000: